Pashtoon Kasi/LinkedIn
Jan 27, 2025, 18:11
Pashtoon Kasi: Another trial unfortunately negative for patients with pancreas cancer
Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, shared on X:
“Another trial unfortunately negative for our patients with pancreas cancer.
As mentioned, innovation is needed.
The PanCAN is a great platform to study novel drugs. While mechanistically, Pamrevlumab was of value to study, it didn’t improve survival.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 14:08
Apr 1, 2025, 12:48
Apr 1, 2025, 12:16
Apr 1, 2025, 12:13
Apr 1, 2025, 12:07